Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial. (Q37117056)
Jump to navigation
Jump to search
scientific article published on 16 April 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial. |
scientific article published on 16 April 2012 |
Statements
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial (English)
John J P Kastelein
Maartje E Visser
Gilbert Wagener
Brenda F Baker
Richard S Geary
Joanne M Donovan
Ulrich H W Beuers
Mieke D Trip
Dick C G Basart
Erik S G Stroes
16 April 2012
1 reference